Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 18Withdrawn 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia 17Leukemia, Myeloid, Acute 15Congenital Abnormalities 14Myelodysplastic Syndromes 13Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 12Burkitt Lymphoma 12Lymphoma, Follicular 11Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 10Leukemia, Myeloid, Accelerated Phase 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hodgkin Disease 10Lymphoma, Large B-Cell, Diffuse 9Leukemia, Myeloid, Chronic-Phase 9Myeloproliferative Disorders 8Lymphoma, B-Cell, Marginal Zone 8Blast Crisis 8Neoplasms, Plasma Cell 7Lymphoma, Large-Cell, Immunoblastic 7Recurrence 6Myelodysplastic-Myeloproliferative Diseases 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Breast Neoplasms 6Sezary Syndrome 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Mycosis Fungoides 5

Interventions

fludarabine phosphate 4Cyclosporine 3Cyclophosphamide 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3ruxolitinib 2fludarabine 2Whole-Body Irradiation 2Stem Cell Transplantation 2Radiotherapy 2Methylprednisolone 2Busulfan 2Antilymphocyte Serum 2nelarabine 1arsenous acid 1anagrelide 1Watchful Waiting 1Thiotepa 1Tetradecanoylphorbol Acetate 1Surveys and Questionnaires 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Observation 1N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide 1Mycophenolic Acid 1Moxifloxacin 1Morphine 1Methotrexate 1Methadone 1Liposomes 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thrombocythemia, Essential × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
51 enrolled
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡